na-apr-1
Vaccineexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2013 (NCT01717950)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tyrosine-protein kinase JAK1Immunity, active
JAK1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- na-apr-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02839161 | Phase 1 | Jan 1, 2017 | Baylor University |
| NCT02476773 | Phase 1 | Jan 1, 2016 | Baylor University, George Washington University, Johns Hopkins University, University of California, San Francisco |
| NCT02126462 | Phase 1 | Nov 1, 2014 | Baylor University |
| NCT01717950 | Phase 1 | Sep 1, 2013 | Baylor University, George Washington University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 4 | 4 | 1 | 2013 |
| George Washington University | Academic/Hospital | 2 | 0 | 1 | 2013 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1